Literature DB >> 31343181

Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence.

Tania Lecomte1, Stéphane Potvin2, Crystal Samson3, Audrey Francoeur3, Catherine Hache-Labelle3, Sarah Gagné3, Johémie Boucher3, Marianne Bouchard3, Kim T Mueser4.   

Abstract

The stress-vulnerability-protective factors model is often used to explain the etiology and known risk and protective factors of initial psychotic symptoms and symptomatic relapses. Over the past 40 years since its initial conception, the model has evolved and gathered a plethora of evidence of varying quality for its different components. The objective of this metareview is to analyze the quality of the evidence and the effect sizes for each component of the model not previously reviewed. Recent meta-analyses covering each component of the model in relation to the onset of psychotic symptoms or symptomatic relapse in schizophrenia were reviewed with the grading of recommendations, assessment, development, and evaluation system. Thirty-one meta-analyses were kept, from 3,044 papers reviewed. We did not add to previous metareviews in terms of obstetric/prenatal or genetic vulnerabilities. For stressors, moderate to strong research evidence was found for childhood adversity, cannabis, methamphetamine abuse, and expressed emotions as triggers of psychotic relapse or as linked to the onset of psychotic symptoms. For protective factors, moderate to strong evidence was found for antipsychotic medication in adults, family interventions, social skills training, as well as interventions focusing on recovery management skills. Poor evidence or no evidence (i.e., absence of meta-analyses) were found for the other components of the model. More rigorous studies and systematic reviews are needed in order to validate the various components of the model in regard to symptom onset and relapse. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Year:  2019        PMID: 31343181     DOI: 10.1037/abn0000447

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  7 in total

Review 1.  Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity.

Authors:  Sophia Vinogradov; Matthew V Chafee; Erik Lee; Hirofumi Morishita
Journal:  Neuropsychopharmacology       Date:  2022-09-30       Impact factor: 8.294

2.  Ethnic identity, stress, and personal recovery outcomes among young adults with serious mental health conditions.

Authors:  Kiara Moore; Michelle R Munson; Rei Shimizu; Aaron H Rodwin
Journal:  Psychiatr Rehabil J       Date:  2022-04-14

3.  Anomaly detection to predict relapse risk in schizophrenia.

Authors:  Philip Henson; Ryan D'Mello; Aditya Vaidyam; Matcheri Keshavan; John Torous
Journal:  Transl Psychiatry       Date:  2021-01-11       Impact factor: 6.222

4.  Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran.

Authors:  Omran Davarinejad; Tahereh Mohammadi Majd; Farzaneh Golmohammadi; Payam Mohammadi; Farnaz Radmehr; Mostafa Alikhani; Tayebeh Motaei; Mehdi Moradinazar; Annette Brühl; Dena Sadeghi Bahmani; Serge Brand
Journal:  Int J Environ Res Public Health       Date:  2021-01-11       Impact factor: 3.390

5.  Hair cortisol, social support, personality traits, and clinical course: differences in schizophrenia and bipolar disorder.

Authors:  Fuzhong Yang; Xiangfei Hong; Jing Tao; Yupeng Chen; Yanbo Zhang; Hua Xiao
Journal:  Brain Behav       Date:  2021-11-13       Impact factor: 2.708

6.  Predicting time to relapse in patients with schizophrenia according to patients' relapse history: a historical cohort study using real-world data in Sweden.

Authors:  Kristian Tore Jørgensen; Martin Bøg; Madhu Kabra; Jacob Simonsen; Michael Adair; Linus Jönsson
Journal:  BMC Psychiatry       Date:  2021-12-21       Impact factor: 3.630

7.  The Canadian Network for Research in Schizophrenia and Psychoses: A Nationally Focused Approach to Psychosis and Schizophrenia Research.

Authors:  Tania Lecomte; Jean Addington; Chris Bowie; Martin Lepage; Stéphane Potvin; Jai Shah; Chris Summerville; Phil Tibbo
Journal:  Can J Psychiatry       Date:  2021-04-19       Impact factor: 4.356

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.